ID: ALA3922843

Max Phase: Preclinical

Molecular Formula: C14H17N3O

Molecular Weight: 243.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Cc1ccccc1)NCCCn1ccnc1

Standard InChI:  InChI=1S/C14H17N3O/c18-14(11-13-5-2-1-3-6-13)16-7-4-9-17-10-8-15-12-17/h1-3,5-6,8,10,12H,4,7,9,11H2,(H,16,18)

Standard InChI Key:  QTCHOYQEJRIXGP-UHFFFAOYSA-N

Associated Targets(non-human)

Lipoprotein lipase 268 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 243.31Molecular Weight (Monoisotopic): 243.1372AlogP: 1.63#Rotatable Bonds: 6
Polar Surface Area: 46.92Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.79CX LogP: 0.99CX LogD: 0.93
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.78Np Likeness Score: -1.72

References

1. Geldenhuys WJ, Caporoso J, Leeper TC, Lee YK, Lin L, Darvesh AS, Sadana P..  (2017)  Structure-activity and in vivo evaluation of a novel lipoprotein lipase (LPL) activator.,  27  (2): [PMID:27913180] [10.1016/j.bmcl.2016.11.053]

Source